Vermetten E

Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.

Meshkat S, Leung M, Meshkat S +13

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Smith SA, Mohammad H, Lee LHN +13

Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis.

Meshkat S, Lin Q, Sousa-Ho R +15

Toward a definition of treatment-resistant posttraumatic stress disorder: A systematic review.

Al-Shamali HF, Meshkat S, Janssen-Aguilar R +12

Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions.

Harkhoe M, Offringa T, Vermetten E

Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.

Janssen-Aguilar R, Meshkat S, Al-Shamali HF +14

Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based Model.

Burback L, Winkler O, Jetly R +4

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Passie T, Loizaga-Velder A, Danforth A +19

Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.

Meshkat S, Malik G, Zeifman RJ +12

Pharmacokinetics of Psilocybin: A Systematic Review.

Meshkat S, Al-Shamali H, Perivolaris A +13

Psychedelics and Suicide-Related Outcomes: A Systematic Review.

Meshkat S, Malik T, Zeifman R +13

Impact of psilocybin on cognitive function: A systematic review.

Meshkat S, Tello-Gerez TJ, Gholaminezhad F +11

Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation.

Herpers J, Maximets N, van Dongen NNN +2

Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.

Yu Z, Burback L, Winkler O +11

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

Breeksema JJ, Niemeijer A, Krediet E +5

ArticleKetamine

Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review.

Burback L, Brémault-Phillips S, Nijdam MJ +2

MDMA for treatment of PTSD and neurorehabilitation in military populations.

Dunn W, Bershad A, Krantz DE +1

Psychedelic and nutraceutical interventions as therapeutic strategies for military-related mild traumatic brain injuries.

Reichelt AC, Vermetten E, Dunkley BT

Europe PMC2023

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions.

Godes M, Lucas J, Vermetten E

Europe PMC2023

ArticleKetamine

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.

Breeksema JJ, Niemeijer A, Kuin B +5

Europe PMC2023

ArticleKetamine

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study.

Breeksema JJ, Niemeijer A, Kuin B +6

Europe PMC2022

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

Breeksema JJ, Kuin BW, Kamphuis J +3

Europe PMC2022

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.

Breeksema JJ, Niemeijer AR, Krediet E +2

Europe PMC2020

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet E, Bostoen T, Breeksema J +3

Europe PMC2020